Role of LAG-3 in regulatory T cells
- PMID: 15485628
- DOI: 10.1016/j.immuni.2004.08.010
Role of LAG-3 in regulatory T cells
Abstract
Regulatory T cells (Tregs) limit autoimmunity but also attenuate the magnitude of antipathogen and antitumor immunity. Understanding the mechanism of Treg function and therapeutic manipulation of Tregs in vivo requires identification of Treg-selective receptors. A comparative analysis of gene expression arrays from antigen-specific CD4(+) T cells differentiating to either an effector/memory or a regulatory phenotype revealed Treg-selective expression of LAG-3, a CD4-related molecule that binds MHC class II. Antibodies to LAG-3 inhibit suppression by induced Tregs both in vitro and in vivo. Natural CD4(+)CD25(+) Tregs express LAG-3 upon activation, which is significantly enhanced in the presence of effector cells, whereas CD4(+)CD25(+) Tregs from LAG-3(-/-) mice exhibit reduced regulatory activity. Lastly, ectopic expression of LAG-3 on CD4(+) T cells significantly reduces their proliferative capacity and confers on them suppressor activity toward effector T cells. We propose that LAG-3 marks regulatory T cell populations and contributes to their suppressor activity.
Similar articles
-
CD4+CD25+ regulatory T cells generated in response to insulin B:9-23 peptide prevent adoptive transfer of diabetes by diabetogenic T cells.J Autoimmun. 2003 Nov;21(3):221-37. doi: 10.1016/s0896-8411(03)00114-8. J Autoimmun. 2003. PMID: 14599847
-
CD4+CD25-LAG-3+ T cells in mouse and human.Nihon Rinsho Meneki Gakkai Kaishi. 2010;33(2):92-8. doi: 10.2177/jsci.33.92. Nihon Rinsho Meneki Gakkai Kaishi. 2010. PMID: 20453445 Review.
-
CD4+CD25+Tregs express an increased LAG-3 and CTLA-4 in anterior chamber-associated immune deviation.Graefes Arch Clin Exp Ophthalmol. 2007 Oct;245(10):1549-57. doi: 10.1007/s00417-007-0591-8. Epub 2007 May 31. Graefes Arch Clin Exp Ophthalmol. 2007. PMID: 17541623
-
CD4+CD25+Foxp3+ regulatory T cells are dispensable for controlling CD8+ T cell-mediated lung inflammation.J Immunol. 2011 Jun 1;186(11):6106-18. doi: 10.4049/jimmunol.1000632. Epub 2011 Apr 25. J Immunol. 2011. PMID: 21518973
-
Dendritic cells expand antigen-specific Foxp3+ CD25+ CD4+ regulatory T cells including suppressors of alloreactivity.Immunol Rev. 2006 Aug;212:314-29. doi: 10.1111/j.0105-2896.2006.00422.x. Immunol Rev. 2006. PMID: 16903923 Review.
Cited by
-
In vitro induction of regulatory CD4+CD8α+ T cells by TGF-β, IL-7 and IFN-γ.PLoS One. 2013 Jul 3;8(7):e67821. doi: 10.1371/journal.pone.0067821. Print 2013. PLoS One. 2013. PMID: 23844100 Free PMC article.
-
Induced and natural regulatory T cells in the development of inflammatory bowel disease.Inflamm Bowel Dis. 2013 Jul;19(8):1772-88. doi: 10.1097/MIB.0b013e318281f5a3. Inflamm Bowel Dis. 2013. PMID: 23656897 Free PMC article. Review.
-
LAG-3: from molecular functions to clinical applications.J Immunother Cancer. 2020 Sep;8(2):e001014. doi: 10.1136/jitc-2020-001014. J Immunother Cancer. 2020. PMID: 32929051 Free PMC article. Review.
-
Development of bispecific antibodies in China: overview and prospects.Antib Ther. 2020 May 30;3(2):126-145. doi: 10.1093/abt/tbaa011. eCollection 2020 Apr. Antib Ther. 2020. PMID: 33928227 Free PMC article. Review.
-
Progress of immune checkpoint LAG-3 in immunotherapy.Oncol Lett. 2020 Nov;20(5):207. doi: 10.3892/ol.2020.12070. Epub 2020 Sep 8. Oncol Lett. 2020. PMID: 32963613 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous